Quality in Sport
August 7, 2026
M. Lewczuk, Natalia Trędota, Zuzanna Czyżewicz et al.
Background: Cluster headache is a severely disabling headache disorder. Despite the availability of acute and preventive therapies, treatment efficacy remains incomplete, leaving many athletes and other patients with insufficient symptom control leading to decreased quality of life and performance. Increasing interest has emerged in psychedelic compounds, particularly psilocybin, as potential...
Quality in Sport
June 20, 2026
Arkadiusz Adam Psiuk
Background: Motor learning in competitive sport relies not only on physical practice but also on the offline reorganisation of memory traces during sleep. Waking motor imagery is a recognised ergogenic adjunct, while recent work suggests that mental rehearsal may be extended into the sleeping brain through lucid dreaming, a state in which the dreamer becomes aware of dreaming while remaining...
Quality in Sport
April 5, 2026
Magdalena Ostaszewska, Milena Majchrzyk, Damian Zienkiewicz et al.
Introduction and aim of the study: 3,4-methylenedioxymethamphetamine (MDMA) is a stimulant drug with widespread consumption. It is used mainly in recreational settings, due to its ability to induce various pleasurable, mood-enhancing effects. Prolonged and excessive MDMA misuse can lead to multiple negative outcomes ranging from cognitive dysfunction or emotional dysregulation to severe...
Quality in Sport
April 3, 2026
Tetiana Savchak, S B Ivanchuk, Anhelina Kaminskaya et al.
Purpose of research: This literature-based review was created to evaluate the effectiveness of yoga and mindfulness-based interventions (MBIs) in managing chronic and acute cancer-related pain. Research materials and methods: A systematic review of literature from 2012 - 2026 across databases including PubMed, Scopus, and Web of Science was conducted. Full-text versions of Meta-Analyses,...
Quality in Sport
April 2, 2026
Milena Majchrzyk, Weronika Walendziak, Magdalena Ostaszewska et al.
Introduction and aim of the study. Substance use disorders, including opioid, cocaine, and alcohol dependence, represent a significant global health challenge with high relapse rates despite existing treatments. Ibogaine, a naturally occurring indole alkaloid derived from Tabernanthe iboga, has attracted increasing scientific interest due to its reported ability to reduce withdrawal symptoms...
Quality in Sport
March 28, 2026
Klaudia Pazio, Michał Piskor, Dominika Strzalińska et al.
Cancer is a major burden in both the somatic and psychological dimensions. Oncology patients often experience high levels of stress, anxiety, depression, and reduced quality of life resulting from both the diagnosis itself and the course of treatment. In recent years, growing attention has been paid to psychosocial interventions that help patients cope with these difficulties. One such approach...
Quality in Sport
January 31, 2026
Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza et al.
Psilocybin-assisted interventions have shown rapid reductions in depressive symptoms in controlled clinical settings, raising questions about biological mechanisms supporting durability beyond the acute drug effect. [5,7] Mechanistic accounts increasingly focus on neuroplasticity as a candidate pathway linking transient serotonergic receptor activation to longer-lasting psychological and...
Quality in Sport
January 26, 2026
Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong et al.
Background: Psychedelic substances have been used for millennia in religious and healing contexts and have recently re-emerged as subjects of scientific interest due to advances in neuroscience and psychiatry. Research suggests that psychedelics may address limitations of conventional psychiatric treatments, particularly in disorders such as major depressive disorder, PTSD, substance use...
Quality in Sport
May 12, 2025
Izabela Zajkowska, Patrycja Niczyporuk, Aleksandra Giba et al.
1 citation
This review explores an innovative, integrative therapeutic approach that combines probiotics, prebiotics, and mindfulness-based interventions (MBIs) to target the dysregulation of the gut–brain axis in schizophrenia. The rationale for this combined strategy is rooted in the overlapping mechanisms by which both biological and psychosocial interventions influence neurophysiological processes....
Quality in Sport
March 21, 2025
Kacper Rusiński, Filip Klimas, Dorota Zatłoka-Mazur et al.
1 citation
Cannabis is one of the most widely used psychoactive substances globally. In several countries, including Canada, the Netherlands, certain U.S. states, and Australia, its possession is legal. With its growing popularity in recent years, the impact of cannabis on mental health has become a focal point of numerous scientific studies. The aim of this review was to summarize the current...
Quality in Sport
July 28, 2024
Weronika Szafrańska, Dominika Poborowska, Tomasz Gańko et al.
Introduction and purpose: Major depressive disorder (MDD) is the most common psychiatric illness, affecting millions of people worldwide. The first line of pharmacological treatment is usually monoamine reuptake inhibitors. Up to 60% of cases, may be drug-resistant patients, prompting researchers to research substances other than conventional. 1 The purpose of this article was to review recent...
Quality in Sport
April 25, 2024
Julia Szymonik, Sebastian Szopa
Introduction: Depression stands as a primary contributor to disability, prompting extensive exploration of treatment and prevention strategies. Recognizing the limitations of conventional approaches, the significance of effective non-pharmacological therapies, like psychotherapy, in managing mental health disorders is increasingly acknowledged. There's a growing interest in mindfulness-based...